Cassava Sciences Announces Patient Enrollment Update for
953 Alzheimer’s Patients Are Now Enrolled Across Phase 3 Studies Both Phase 3 Studies Have Passed the Halfway Mark for Enrollment Goal Is to Complete...
Source: globenewswire.com
Stay updated with breaking news from Both Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
953 Alzheimer’s Patients Are Now Enrolled Across Phase 3 Studies Both Phase 3 Studies Have Passed the Halfway Mark for Enrollment Goal Is to Complete...
· Novartis and Medicines for Malaria Venture (MMV) announce decision to move to Phase 3 study for novel non-artemisinin combination to treat uncomplicated
News Release Takeda Submits New Drug Application for Novavax' COVID-19 Vaccine Candidate in Japan ... | December 16, 2021